Drug Profile
Research programme: antibacterials - Uteron Pharma
Alternative Names: Antivag; Biovag; VaginateLatest Information Update: 04 Nov 2017
Price :
$50
*
At a glance
- Originator Uteron Pharma
- Class
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- No development reported Vaginitis
Most Recent Events
- 04 Nov 2017 No recent reports of development identified for preclinical development in Vaginitis(Recurrent) in Belgium
- 23 Jan 2013 Preclinical trials in Vaginitis in Belgium (unspecified route)